Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial

Comparable long-term mortality risk associated with individual sulfonylureas in diabetes patients with heart failure

(2011) Charlotte Andersson et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study

(2011) Tina Ken Schramm et al.   EUROPEAN HEART JOURNAL

Acute heart failure in patients with diabetes mellitus: Clinical characteristics and predictors of in-hospital mortality

(2011) John T. Parissis et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008

(2011) Jersey Chen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Rosiglitazone Revisited

(2010) Steven E. Nissen et al.   ARCHIVES OF INTERNAL MEDICINE

Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure

(2010) Veli-Pekka Harjola et al.   EUROPEAN JOURNAL OF HEART FAILURE

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

(2009) Philip D Home et al.   LANCET

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: An analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

(2008) M. R. MacDonald et al.   EUROPEAN HEART JOURNAL

Clinical Implications of QRS Duration in Patients Hospitalized With Worsening Heart Failure and Reduced Left Ventricular Ejection Fraction

(2008) Norman C. Wang   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION